Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
NeueHealth Inc (NEUE)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/02/2025: NEUE (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
2 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $7
1 Year Target Price $7
| 0 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -80.59% | Avg. Invested days 15 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/02/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 61.16M USD | Price to earnings Ratio - | 1Y Target Price 7 |
Price to earnings Ratio - | 1Y Target Price 7 | ||
Volume (30-day avg) 2 | Beta 0.56 | 52 Weeks Range 3.79 - 7.66 | Updated Date 07/2/2025 |
52 Weeks Range 3.79 - 7.66 | Updated Date 07/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -22.42 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -14.38% | Operating Margin (TTM) 1.23% |
Management Effectiveness
Return on Assets (TTM) -4.13% | Return on Equity (TTM) -183.26% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 1044867142 | Price to Sales(TTM) 0.07 |
Enterprise Value 1044867142 | Price to Sales(TTM) 0.07 | ||
Enterprise Value to Revenue 1.15 | Enterprise Value to EBITDA -0.73 | Shares Outstanding 8927760 | Shares Floating 3781852 |
Shares Outstanding 8927760 | Shares Floating 3781852 | ||
Percent Insiders 9.56 | Percent Institutions 59.33 |
Analyst Ratings
Rating 1 | Target Price 7 | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold 1 | Sell 1 | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
NeueHealth Inc
Company Overview
History and Background
NeueHealth Inc. was founded in 2015, initially operating as Bright Health Group, a technology-enabled, risk-bearing healthcare company. The company focused on building its care model through its affiliated NeueCare provider network. In 2024, Bright Health Group restructured, selling off its Medicare Advantage business and rebranding as NeueHealth Inc., focusing solely on its care delivery business.
Core Business Areas
- NeueCare: NeueCare encompasses a network of affiliated primary and specialty care clinics that operate under value-based care arrangements. These arrangements focus on improving patient outcomes while managing costs.
- Technology and Enablement Services: NeueHealth provides technology and services to support its NeueCare provider network and other healthcare organizations, including care coordination, data analytics, and population health management tools.
Leadership and Structure
NeueHealth Inc. is led by Mark Vonder Haar as CEO. The organizational structure is designed to support the company's focus on value-based care and technological integration. Specific details regarding all executives are available on their website.
Top Products and Market Share
Key Offerings
- NeueCare Clinics: A network of primary and specialty care clinics operating under value-based care contracts. Market share data is difficult to pinpoint because they operate in certain regions and because of their relative young standing as a stand alone business after the restructuring from Bright Health. Competitors include Oak Street Health (now part of CVS Health), Privia Health, and VillageMD.
- Technology and Enablement Platform: Technology solutions that support care coordination, data analytics, and population health management for the NeueCare network and external partners. No specific market share available given niche focus and integrated nature with NeueCare. Competitors include other healthcare technology providers, such as athenahealth and Epic Systems, though they serve a wider market.
Market Dynamics
Industry Overview
The healthcare industry is undergoing a shift towards value-based care, with increasing emphasis on improving patient outcomes and managing costs. Technological innovation and data analytics are playing a crucial role in driving this transformation.
Positioning
NeueHealth is positioned as a technology-enabled care delivery company focused on value-based care. Its competitive advantage lies in its integrated NeueCare provider network and technology platform, enabling it to effectively manage patient populations and improve healthcare outcomes.
Total Addressable Market (TAM)
The TAM for value-based care and healthcare technology solutions is substantial and growing. Estimates vary, but generally experts believe the TAM to be in the hundreds of billions of dollars. NeueHealth is positioned to capture a portion of this market through its integrated care model and technology offerings.
Upturn SWOT Analysis
Strengths
- Integrated care delivery model
- Technology-enabled platform
- Focus on value-based care
- Experienced leadership team
- Established provider network
Weaknesses
- Relatively new stand alone company after restructuring and rebranding
- Limited brand recognition post restructuring
- Geographic concentration risk
- Dependent on value-based care contracts
Opportunities
- Expansion into new geographic markets
- Partnerships with other healthcare organizations
- Increased adoption of value-based care
- Technological innovation and development
- Government initiatives supporting healthcare reform
Threats
- Changes in healthcare regulations
- Increased competition from established players
- Economic downturn impacting healthcare spending
- Data security and privacy concerns
- Reimbursement rate changes
Competitors and Market Share
Key Competitors
- CVS (CVS)
- One Medical (AMZN)
- Privia Health Group (PRVA)
Competitive Landscape
NeueHealth faces competition from established healthcare providers, technology companies, and other value-based care organizations. Its success will depend on its ability to differentiate itself through its integrated care model, technology platform, and focus on patient outcomes.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is linked to Bright Health Group's previous business model, which is not indicative of NeueHealth's current strategy.
Future Projections: Future projections are uncertain but dependent on its ability to expand its NeueCare network, form new partnerships, and capitalize on the growing demand for value-based care. The companies success is based on if it can reduce costs and manage their revenue streams.
Recent Initiatives: Recent initiatives include focusing on its core NeueCare business, divesting non-core assets, and rebranding as NeueHealth Inc.
Summary
NeueHealth is a newly focused healthcare company built on value-based care, but it faces challenges due to its recent restructuring and competition within the market. Its integrated care model and tech-enabled platform offer advantages but are also dependent on successful contracts. Future growth is possible through expansion and partnerships. However, it must be wary of regulatory changes and economic factors.
Peer Comparison
Sources and Disclaimers
Data Sources:
- NeueHealth Inc. Investor Relations
- SEC Filings (historical Bright Health Group)
- Industry reports and analysis
Disclaimers:
The information provided is for informational purposes only and should not be construed as financial advice. Investment decisions should be based on individual circumstances and consultation with a qualified financial advisor. Market share and other financial data are estimates and may not be precise. Limited data is available post-restructuring. The above AI rating is subject to the limitations of the information available and should not be interpreted as a guaranteed indication of future performance.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About NeueHealth Inc
Exchange NYSE | Headquaters Doral, FL, United States | ||
IPO Launch date 2021-06-24 | Vice Chairman, CEO & President Mr. George Lawrence Mikan III | ||
Sector Healthcare | Industry Healthcare Plans | Full time employees 986 | Website https://www.neuehealth.com |
Full time employees 986 | Website https://www.neuehealth.com | ||
NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates in two segments, NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health and Premier Medical Associates brand names. This segment also offers integrated system care solutions, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.